Galectin Therapeutics Inc.

NASDAQ:GALT

Biotechnology

Healthcare
$2.91 +1.62%

+$0.05 today

Market cap
$191.64M
Beta
0.49
P/E (TTM)
-7.1
EPS (TTM)
-$0.40
52W Low $1.85High $7.13

Volume 0.26M

Average 0.32M

Price history

Galectin Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-52.99%

Period high

$6.51

Period low

$2.08

Latest

$2.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
DEFA14AOct 13, 2026Oct 13, 2026
DEF 14AOct 13, 2026Oct 13, 2026
ARSOct 13, 2026Oct 13, 2026
PRE 14AOct 2, 2026Oct 2, 2026
10-QAug 14, 2026Aug 14, 2026
8-KAug 14, 2026Aug 14, 2026
SC 13D/AAug 4, 2026Aug 4, 2026
8-KAug 4, 2026Aug 4, 2026
4Aug 4, 2026Aug 4, 2026
4Jul 16, 2026Jul 16, 2026
4Jun 30, 2026Jun 30, 2026
4Jun 30, 2026Jun 30, 2026
4Jun 25, 2026Jun 25, 2026
8-KJun 23, 2026Jun 23, 2026
4May 28, 2026May 28, 2026

Competitors

Who does Galectin Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GALT's filings, answered from its disclosures.

What is the latest GALT filing?

The latest filing shown is ARS dated Oct 13, 2026.

How many recent filings does GALT have?

Intrinsic Alpha currently shows 20 recent filings for GALT.